Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.64 |
| ▸ | CA2 | P00918 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | STS | P08842 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ACR | P10323 | 1/20 | 0.46 |
| ▸ | HGFAC | Q04756 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31072061 | 0.94 | CA1 (0.58) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL31072060 | 0.94 | CA1 (0.58) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL29220093 | 0.91 | CA1 (0.55) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL28095252 | 0.91 | CA1 (0.55) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL29472012 | 0.88 | CA1 (0.55) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL7929490 | 0.86 | CA1 (0.67) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL29894371 | 0.83 | CA1 (0.44) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL28067352 | 0.82 | CA1 (0.56) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL23600 | 0.80 | CA1 (0.80) | CA1CA2MAPTTDP1CA12 | |
| SCHEMBL28993944 | 0.80 | CA1 (0.80) | CA1CA2MAPTTDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011038-A | Linear Pt (NHC) for constructing MOFs2Metal organic carboxylic acid ligand, preparation method and application thereof | 蚌埠医科大学 | 2026-05-12 | — | — | CN | claimed |
| CN-119978416-A | Metal organic framework material based on dodecacarboxyl organic ligand, synthesis and natural gas purification application thereof | 浙江大学杭州国际科创中心 | 2025-05-13 | — | — | CN | claimed |
| CN-119331264-A | Pyrenyl metal organic framework material suitable for low-temperature methane adsorption storage, and preparation and application thereof | 浙江大学杭州国际科创中心 | 2025-01-21 | — | — | CN | claimed |
| CN-119306665-A | 3- (1- (2, 4-Dichlorobenzyl) -1H-indazol-3-yl) benzoyl hydrazine, and preparation method and application thereof | 浙江大学医学院附属邵逸夫医院（浙江省邵逸夫医院） | 2025-01-14 | — | — | CN | claimed |
| CN-119019229-A | Synthesis method of beta-gem difluorophenethyl alcohol or beta-gem difluorophenethyl ether compound and analogues thereof | 中国科学技术大学 | 2024-11-26 | — | — | CN | claimed |
| CN-116496506-B | Preparation method and application of mesoporous crystalline material with super-large primary three-dimensional cage structure | 武汉大学 | 2024-05-03 | — | — | CN | claimed |
| CN-117486823-A | Nile blue derivative compound and preparation method and application thereof | 西湖大学 | 2024-02-02 | — | — | CN | claimed |
| CN-116496506-A | Preparation method and application of mesoporous crystalline material with super-large primary three-dimensional cage structure | 武汉大学 | 2023-07-28 | — | — | CN | claimed |
| CN-107540848-A | A kind of preparation and its application of efficiently out-phase hydrogen-bond donor MOF catalyst | 合肥工业大学 | 2018-01-05 | — | — | CN | claimed |
| EP-0973704-B1 | PROCESS FOR THE MANUFACTURE OF ARYLSULFONYL CHLORIDE | ASTRAZENECA AB (SE) | 2004-10-06 | — | — | EP | claimed |
| CN-122029970-A | Photoelectric conversion element and solar cell module | 株式会社安能科多科技 | 2026-05-12 | — | — | CN | disclosed |
| CN-122011038-A | Linear Pt (NHC) for constructing MOFs2Metal organic carboxylic acid ligand, preparation method and application thereof | 蚌埠医科大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-119978416-A | Metal organic framework material based on dodecacarboxyl organic ligand, synthesis and natural gas purification application thereof | 浙江大学杭州国际科创中心 | 2025-05-13 | — | — | CN | disclosed |
| CN-116157398-B | Oxadiazole-based selective histone deacetylase 6 inhibitors | 意大发马克股份公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119330893-A | Resolution method of nitrogen heterocyclic derivative | 南京正大天晴制药有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-1678591-A | Novel carboxamide compounds having MCH-antagonistic action, pharmaceutical preparations comprising said compounds and process for their preparation | BOEHRINGER INGELHEIM INT (DE) | 2005-10-05 | — | — | CN | disclosed |
| US-20040242572-A1 | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-12-02 | — | — | US | disclosed |
| EP-1140896-A1 | BENZOTHIEPIN-ANILIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR ANTAGONIZING CCR-5 | Takeda Chemical Industries, Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-6235771-B1 | AIDS THERPAY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| WO-2000037455-A1 | BENZOTHIEPIN-ANILIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR ANTAGONIZING CCR-5 | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242572-A1 | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture | MCHR2, MCHR1, NPY1R | CA1 4351/4885CA2 952/4885MAPT 4481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.